Published
Oxford's R21/Matrix-M malaria vaccine has been proven highly effective. It has been trialled in Burkina Faso, Kenya, Mali and Tanzania.
The WHO has recommended the vaccine for use in countries around the world. Agreements are in place to deliver hundreds of millions of doses.
Malaria kills hundreds of thousands every year, mostly young children. R21/Matrix-M could reduce that great loss, alongside existing malaria controls.
The WHO has recommended the vaccine for use in countries around the world. Agreements are in place to deliver hundreds of millions of doses.
Malaria kills hundreds of thousands every year, mostly young children. R21/Matrix-M could reduce that great loss, alongside existing malaria controls.
- Category
- Academic
- Tags
- University of Oxford, Oxford, University
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
05:07
Vaccine Skeptic to Lead National Vaccine Safety Review?
-
03:29
3 Supplements This Doctor Recommends
-
00:55
The Black Death today: Oxford launches clinical trial of a plague vaccine
-
02:52
Why Malaria Isn’t Just a Tropical Disease
-
02:01
African Research, Oxford Vaccine
-
08:23
Malaria vaccine launched - News Review
-
01:39
This Doctor Recommends These 3 Healthy Oils
-
07:13
The key to a better malaria vaccine | Faith Osier
-
02:31
The One Supplement She Recommends For Everyone!
-
00:55
Oxford's malaria vaccine - The story so far
-
06:31
Oxford Social Finance Leadership Series: Peter Tufano, Oxford Saïd
-
00:41
Oxford launches its first results from the COVID-19 vaccine trial
-
00:41
Oxford vaccine reaches one billion doses released
-
02:17
Malaria: The devil we know
-
00:49
Oxford launches trials for new oral vaccine against paratyphoid
-
01:57
Five Supplements This Doctor Recommends!
-
02:30
Oxford's scientists explain the Phase I/II results for the COVID-19 vaccine
-
16:51
Malaria Elimination in ASEAN
-
00:48
Oxford University's 'vaccine for the world' is effective
-
08:13
First Malaria Vaccine, 'Brain Pacemaker', Stagflation, Chili Peppers & Rent | Stories of the Week
-
00:40
Oxford University Press announce shortlist for the 2024 Oxford Word of the Year #OxfordWOTY
-
03:20
Oxford's COVID-19 vaccine is highly effective: Phase III trial interim results
